相关实验视频
Updated: Jul 22, 2025

10:32
Development of a Virtual Reality Assessment of Everyday Living Skills
Published on: April 23, 2014
18.5K
在管理痴呆症神经精神病症状的ABCD方法
1Amy Siple is a national speaker on healthcare issues that impact older adults and the empowerment of healthcare givers. She has served the primary care needs of residents in long-term care as an NP for over 2 decades.
Nursing
|July 20, 2023
概括
对于护理人员来说,管理痴呆症中的神经精神症状是具有挑战性的. 这篇文章提供了实用策略,以帮助导航这些困难的行为和改善护理.
科学领域:
- 老年学和神经精神病学.
- 痴呆症护理研究研究
背景情况:
- 神经精神症状 (NPS) 是痴呆症护理中的一个重大负担.
- 这些症状,通常被称为"不必要的行为",给家庭和专业的护理人员带来了相当大的挑战.
- 有效的管理策略对于患者的福祉和护理人员的支持至关重要.
研究的目的:
- 概述基于证据的策略,用于管理痴呆症神经精神病症状.
- 为面对与痴呆相关的行为挑战的护理人员提供实际指导.
主要方法:
- 审查有关痴呆症相关神经精神病症状的当前文献.
- 对护理人员的管理方法和最佳实践的综合.
- 在适当的情况下,专注于非药理和药理干预措施.
主要成果:
- 确定需要管理的关键神经精神病症状.
- 介绍了评估和干预行为障碍的框架.
- 强调个性化护理计划的重要性.
结论:
- 实施有针对性的策略可以有效地管理与痴呆有关的神经精神病症状.
- 护理人员的教育和支持对于成功的痴呆症护理至关重要.
- 改善NPS的管理可以提高痴呆症患者及其照顾者的生活质量.
相关概念视频
Alzheimer's Disease: Treatment
219
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
219
Alzheimer's Disease: Overview
525
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
525
Drug Therapy
72
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
72
Psychosis: Goals of Pharmacotherapy
168
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
168
Dementia
141
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
141
Parkinson's Disease: Treatment
301
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
301

